Crista Galli Ventures

What is Crista Galli Ventures?

Crista Galli Ventures is a European investment fund that specializes in providing capital to ambitious healthtech companies at the Seed and Series A stages. They aim to forge a patient-centric future by investing in groundbreaking companies that leverage healthcare data and technology to transform the healthcare industry.

As a venture capital fund, they value deep medical expertise and have a strong network to support founders in building significant, world-class healthcare businesses.

At the heart of their investment thesis is the belief that AI can augment the skills of medical professionals, enhance diagnosis and treatment processes, and optimize physicians' workflow—ultimately saving lives. Crista Galli Ventures also focuses on digital health to improve healthcare delivery and patient outcomes by digitizing all aspects of healthcare from providers to patients. Further, they invest in personalized healthcare, favoring innovations that offer treatments tailored to individual patients' epigenetics, microbiome, and genome.

Their approach is agile, offering expedited, single-source investment opportunities with practical timeframes across multiple funding stages. They deploy up to 500k euros at the Seed stage or for the first investment ticket, and up to 3 million euros at Series A or for the second ticket.

Crista Galli Ventures extends its investment umbrella to pre-Seed stages through Crista Galli LABS for exceptional founders. The fund boasts leadership by a former NHS radiologist and an experienced investor, bringing a unique blend of frontline health experience and financial acumen.

A panel of trusted advisors with strong ties in healthcare and finance provides founders with access to global networks. Evolving to meet the needs of modern healthcare, Crista Galli Ventures is gearing up to launch a new chapter with a redesigned website that reflects their renewed commitment to shape healthcare's future through cutting-edge investments.